NCT02424175View on ClinicalTrials.gov

Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 1, 2016

Primary Completion Date

August 30, 2017

Study Completion Date

May 8, 2018

Conditions
Sclerosing Cholangitis
Interventions
BIOLOGICAL

Fecal Microbiota Transplantation

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER

NCT02424175 - Fecal Microbiota Transplantation for the Treatment of Primary Sclerosing Cholangitis. | Biotech Hunter | Biotech Hunter